ATE485298T1 - Pteridinonderivate als inhibitoren von pi3- kinasen - Google Patents

Pteridinonderivate als inhibitoren von pi3- kinasen

Info

Publication number
ATE485298T1
ATE485298T1 AT08708304T AT08708304T ATE485298T1 AT E485298 T1 ATE485298 T1 AT E485298T1 AT 08708304 T AT08708304 T AT 08708304T AT 08708304 T AT08708304 T AT 08708304T AT E485298 T1 ATE485298 T1 AT E485298T1
Authority
AT
Austria
Prior art keywords
kinases
inhibitors
pteridinone derivatives
pteridinone
derivatives
Prior art date
Application number
AT08708304T
Other languages
English (en)
Inventor
Riccardo Giovannini
Sara Frattini
Trixi Brandl
Steffen Breitfelder
Enzo Cereda
Matthias Grauert
Matthias Hoffmann
Anne T Joergensen
Udo Maier
Alexander Pautsch
Monica Quai
Stefan Scheuerer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE485298T1 publication Critical patent/ATE485298T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08708304T 2007-02-01 2008-01-28 Pteridinonderivate als inhibitoren von pi3- kinasen ATE485298T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07101544A EP1953163A1 (de) 2007-02-01 2007-02-01 Pteridinon-Derivate als PI3-Kinases Inhibitoren
PCT/EP2008/050986 WO2008092831A1 (en) 2007-02-01 2008-01-28 Pteridinone derivatives as pi3-kinases inhibitors

Publications (1)

Publication Number Publication Date
ATE485298T1 true ATE485298T1 (de) 2010-11-15

Family

ID=38054568

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08708304T ATE485298T1 (de) 2007-02-01 2008-01-28 Pteridinonderivate als inhibitoren von pi3- kinasen

Country Status (11)

Country Link
US (1) US8410100B2 (de)
EP (2) EP1953163A1 (de)
JP (1) JP5484072B2 (de)
AR (1) AR065123A1 (de)
AT (1) ATE485298T1 (de)
CA (1) CA2677168C (de)
CL (1) CL2008000287A1 (de)
DE (1) DE602008003098D1 (de)
ES (1) ES2352443T3 (de)
TW (1) TW200838538A (de)
WO (1) WO2008092831A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2725014C (en) 2008-05-30 2014-06-17 Amgen Inc. Inhibitors of pi3 kinase
CN102020643A (zh) 2009-09-22 2011-04-20 上海恒瑞医药有限公司 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
US9351974B2 (en) 2011-11-10 2016-05-31 OSI Pharmaceuticals, LLC Substituted pteridinones for the treatment of cancer
CN103664845B (zh) * 2013-12-27 2016-02-10 湖南欧亚生物有限公司 一种Plk激酶抑制剂药物中间体7-氨基-2,3-二氢苯并呋喃-4-甲酸的制备方法
KR20180132812A (ko) * 2016-04-07 2018-12-12 다나-파버 캔서 인스티튜트 인크. 피리미도-디아제피논 키나아제 스캐폴드 화합물 및 ｐｉ3ｋ-매개된 장애의 치료 방법
CN110343109B (zh) * 2019-08-21 2021-11-23 郑州大学 一种二氢蝶啶酮-磺酰胺类衍生物及其药学上可接受的盐、其制备方法及其应用
CN115124473B (zh) * 2022-07-12 2023-11-10 河北科技大学 西咪替丁有关物质b的合成方法
CN117466785B (zh) * 2023-11-02 2026-03-03 韶远科技（上海)有限公司 一种2-卤代-4-(甲基磺酰基)-1-硝基苯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169778B2 (en) * 1999-09-15 2007-01-30 Warner-Lambert Company Pteridinones as kinase inhibitors
UA76512C2 (en) * 2001-09-04 2006-08-15 Boehringer Ingelheim Pharma Dihydropteridinones, a method for producing thereof and use thereof as medicament
ATE411996T1 (de) * 2002-09-30 2008-11-15 Bayer Healthcare Ag Kondensierte azolpyrimidinderivate
WO2004052373A1 (en) * 2002-12-06 2004-06-24 Warner-Lambert Company Llc Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
JP3876265B2 (ja) 2003-02-26 2007-01-31 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ジヒドロプテリジノン、その製造方法及び薬物形態での使用
WO2005113556A1 (en) * 2004-05-13 2005-12-01 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006091737A1 (en) * 2005-02-24 2006-08-31 Kemia, Inc. Modulators of gsk-3 activity

Also Published As

Publication number Publication date
US20100099680A1 (en) 2010-04-22
ES2352443T3 (es) 2011-02-18
EP2114945B1 (de) 2010-10-20
CA2677168A1 (en) 2008-08-07
CA2677168C (en) 2016-09-27
WO2008092831A1 (en) 2008-08-07
JP5484072B2 (ja) 2014-05-07
JP2010517957A (ja) 2010-05-27
US8410100B2 (en) 2013-04-02
CL2008000287A1 (es) 2008-05-23
TW200838538A (en) 2008-10-01
EP1953163A1 (de) 2008-08-06
EP2114945A1 (de) 2009-11-11
DE602008003098D1 (de) 2010-12-02
AR065123A1 (es) 2009-05-20

Similar Documents

Publication Publication Date Title
CY2021001I2 (el) Παραγωγα ετεροκυκλικου αμιδιου χρησιμα ως μικροβιοκτονα
ATE543816T1 (de) Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase
EP2192838A4 (de) Heterocyclische nekroptose-hemmer
SMT201600267B (it) Inibitori di syk imidazopirazinici
EP2346508A4 (de) Heterocyclische kinasehemmer
DE602005025733D1 (de) Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase
ATE537147T1 (de) Azabiphenylaminobenzoesäurederivate als dhodh- inhibitoren
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
CY2017005I2 (el) Μακροκυκλικες ενωσεις κινοξαλινης ως αναστολεις πρωτεασεις ns3 του hcv
ATE496029T1 (de) Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
ATE478064T1 (de) Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate
DK2389382T3 (da) Aminoheterocykliske forbindelser anvendt som pde9-inhibitorer
ATE510825T1 (de) Acylaminopyrazole als fgfr-inhibitoren
CR10369A (es) Pyrimidine derivatives as pi3k inhibitors
IL230580A0 (en) Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
ATE551342T1 (de) Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
ATE471939T1 (de) Heterocyclische spiro-verbindungen als aldosteronsynthaseinhibitoren
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
BRPI0907061A2 (pt) Derivados de 2-aminoquinolina úteis como inibidores de beta-secretase (base)
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DE602006011363D1 (de) Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
EP2299999A4 (de) Stat3-inhibitoren
ATE549340T1 (de) Spiroindolinon-derivate als mdm2-p53 inhibitoren
BRPI0811516A2 (pt) Compostos e composições como inibidores de c-kit e pdgfr cinase
CR10879A (es) Cyclized derivatives as eg-5 inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2114945

Country of ref document: EP